The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

Kraft Heinz vows to phase out artificial dyes by the end of 2027 — but points out most of their products are already dye-free ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Kraft Heinz announced that it plans to remove all synthetic food dyes from its U.S. product portfolio by the end of 2027.

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

The Johns Hopkins-led and NIH funded OUtMATCH study led to the development of Xolair, a groundbreaking drug that reduces the ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...